NewLeaf Symbiotics

OverviewSuggest Edit

NewLeaf Symbiotics was formed to develop and commercialize one of the most prevalent, beneficial bacteria found in nature: PPFMs (Pink Pigmented Facultative Methylotrophs). NewLeaf Symbiotics is the exclusive licensee of a number of patents on the use of this family of bacteria. NewLeaf Symbiotics has also filed its own related patents, and is actively developing new technologies related to PPFMs. The Company is engaged in laboratory, greenhouse, and field product trials.
HQCreve Coeur, MO, US

Recent NewsAll News

Latest Updates

Employees (est.) (Feb 2021)40
Cybersecurity ratingBMore

Key People/Management at NewLeaf Symbiotics

Steve Kahn

Steve Kahn

Chief Executive Officer, Director
Janne Kerovuo

Janne Kerovuo

Chief Technology Officer
Sanjeev Krishnan

Sanjeev Krishnan

Mike McFatrich

Mike McFatrich

Vice President Business Strategy & Development
John Pasquesi

John Pasquesi

Maureen Mazurek

Maureen Mazurek

Vice President of Communications
Show more

NewLeaf Symbiotics Office Locations

NewLeaf Symbiotics has an office in Creve Coeur
Creve Coeur, MO, US (HQ)
1005 N Warson Rd
Show all (1)

NewLeaf Symbiotics Financials and Metrics

Summary Metrics

Founding Date


NewLeaf Symbiotics total Funding

$57.6 m

NewLeaf Symbiotics latest funding size

$6 m

Time since last funding

3 years ago

NewLeaf Symbiotics investors

NewLeaf Symbiotics's latest funding round in September 2017 was reported to be $6 m. In total, NewLeaf Symbiotics has raised $57.6 m
Show all financial metrics

NewLeaf Symbiotics Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

NewLeaf Symbiotics Online and Social Media Presence

Embed Graph

NewLeaf Symbiotics News and Updates

NewLeaf Symbiotics nabs $24 mln Series C

St. Louis, Missouri-based NewLeaf Symbiotics, an agricultural biotech company, has secured $24 million in Series C financing. Monsanto Growth Ventures and Otter Capital led the round with participation from other backers that included Lewis & Clark Ventures, Rockport Capital, Pangaea Ventures an…

NewLeaf Symbiotics Blogs

NewLeaf Symbiotics Completes Final Close of Series D Financing with the Addition of a New Strategic Investor

NewLeaf Symbiotics completes final close of its Series D financing; SABIC Ventures US Holdings LLC joins as strategic investor   ST. LOUIS, December 1, 2020 – NewLeaf Symbiotics, Inc. (NewLeaf) announced that it recently completed the final close of its Series D financing as it broadens and accelera…

Terrasym for Corn: Early Season Results

After extensively examining the data from our field trials, we’re excited to share insights from our early season field visits of Terrasym for Corn! Overview NewLeaf Symbiotics is partnering with independent data company IN10T and their expansive FarmerTrials Network this growing season to bring com…

NewLeaf Symbiotics to Host Virtual Field Day on June 1

ST. LOUIS, Mo – NewLeaf Symbiotics® is excited to host its first Virtual Field Day to showcase early season results of Terrasym®. The Virtual Field Day will give farmers and others in the agriculture community the opportunity to view Terrasym’s corn and soybean trial progress while minimizing in-per…

NewLeaf Symbiotics Partners with IN10T’s FarmerTrials Network to Demonstrate Benefits of Microbial Ag Products

For Release February 27, 2020 ST. LOUIS, Mo – NewLeaf Symbiotics (NewLeaf), a plant microbiome technology company, has initiated a partnership with IN10T® (“intent”) to test its M-troph microbial product line Terrasym® with farmers. The company will tap into IN10T’s extensive FarmerTrials Network to…

NewLeaf Symbiotics Raises $20 million in a first close of its Series D Financing, Focuses on Accelerating Commercialization

Farmers Poised to Benefit from NewLeaf’s Innovative Microbial Products ST. LOUIS, February 24, 2020 – NewLeaf Symbiotics, Inc. (NewLeaf) announced today that it has raised $20 million in a first close of its Series D financing as it broadens and accelerates product commercialization. Koch Agronomic …

Microbes Play a Crucial Role in Farming, a Thirty Year Journey

by Desmond Jimenez, Chief Product Officer July was significant for NewLeaf Symbiotics and agriculture. We announced a long-term partnership with Joyn Bio. Together, New Leaf and Joyn will work collectively to accelerate our shared vision to bring economic innovation and ecological resilience to glob…
Show more

NewLeaf Symbiotics Frequently Asked Questions

  • When was NewLeaf Symbiotics founded?

    NewLeaf Symbiotics was founded in 1999.

  • Who are NewLeaf Symbiotics key executives?

    NewLeaf Symbiotics's key executives are Steve Kahn, Janne Kerovuo and Sanjeev Krishnan.

  • How many employees does NewLeaf Symbiotics have?

    NewLeaf Symbiotics has 40 employees.

  • Who are NewLeaf Symbiotics competitors?

    Competitors of NewLeaf Symbiotics include Joyn Bio, Anpario and Biotalys.

  • Where is NewLeaf Symbiotics headquarters?

    NewLeaf Symbiotics headquarters is located at 1005 N Warson Rd, Creve Coeur.

  • Where are NewLeaf Symbiotics offices?

    NewLeaf Symbiotics has an office in Creve Coeur.

  • How many offices does NewLeaf Symbiotics have?

    NewLeaf Symbiotics has 1 office.